MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1073/pnas.1015557108

Медицинская библиотека · Proceedings of the National Academy of Sciences of the United States of America · 2011

Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.

Franco Aime T, Malaguarnera Roberta, Refetoff Samuel, Liao Xiao-Hui, Lundsmith Emma, Kimura Shioko, Pritchard Catrin, Marais Richard, Davies Terry F, Weinstein Lee S, Chen Min, Rosen Neal, Ghossein Ronald, Knauf Jeffrey A, Fagin James A

СтатьяПоддержка NIH: внешняя программаResearch Support, N.I.H., IntramuralПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Mutations of BRAF are found in ∼45% of papillary thyroid cancers and are enriched in tumors with more aggressive properties. We developed mice with a thyroid-specific knock-in of oncogenic Braf (LSL-Braf(V600E)/TPO-Cre) to explore the role of endogenous expression of this oncoprotein on tumor initiation and progression. In contrast to other Braf-induced mouse models of tumorigenesis (i.e., melanomas and lung), in which knock-in of Braf(V600E) induces mostly benign lesions, Braf-expressing thyrocytes become transformed and progress to invasive carcinomas with a very short latency, a process that is dampened by treatment with an allosteric MEK inhibitor. These mice also become profoundly hypothyroid due to deregulation of genes involved in thyroid hormone biosynthesis and consequently have high TSH levels. To determine whether TSH signaling cooperates with oncogenic Braf in this process, we first crossed LSL-Braf(V600E)/TPO-Cre with TshR knockout mice. Although oncogenic Braf was appropriately activated in thyroid follicular cells of these mice, they had a lower mitotic index and were not transformed. Thyroid-specific deletion of the Gsα gene in LSL-Braf(V600E)/TPO-Cre/Gnas-E1(fl/fl) mice also resulted in an attenuated cancer phenotype, indicating that the cooperation of TshR with oncogenic Braf is mediated in part by cAMP signaling. Once tumors were established in mice with wild-type TshR, suppression of TSH did not revert the phenotype. These data demonstrate the key role of TSH signaling in Braf-induced papillary thyroid cancer initiation and provide experimental support for recent observations in humans pointing to a strong association between TSH levels and thyroid cancer incidence.

Для цитирования: Franco Aime T, Malaguarnera Roberta, Refetoff Samuel, Liao Xiao-Hui, Lundsmith Emma, Kimura Shioko, Pritchard Catrin, Marais Richard, Davies Terry F, Weinstein Lee S, Chen Min, Rosen Neal, Ghossein Ronald, Knauf Jeffrey A, Fagin James A. Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.. Proceedings of the National Academy of Sciences of the United States of America. 2011. DOI: 10.1073/pnas.1015557108.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.